Insights

Expanding Reach Genomind has recently partnered with large healthcare organizations such as Shore Quality Partners and Parkview Medical Center, indicating a growing acceptance of their genetic testing solutions within integrated care networks and regional health systems.

Diverse Service Portfolio With offerings extending from pharmacogenetic testing to direct-to-consumer mental health genetic insights and interactive decision support tools like GenMed Pro, Genomind presents multiple touchpoints for engaging different segments of healthcare providers and patients.

Technological Integration By integrating with electronic health records such as Epic and leveraging digital tools, Genomind demonstrates a commitment to seamless workflow adoption, creating opportunities to pitch compatible software solutions and EHR integrations.

Market Growth Having achieved coverage of 100 million lives and expanding its provider network, Genomind is positioned for growth in mental health and personalized medicine, offering potential sales pathways with large health plans, provider groups, and employer health programs.

Financial Opportunity With revenue estimates between 25 million and 50 million and recent funding rounds, there is budget available for expanding partnerships, meaningful technology upgrades, and enhanced service offerings within the precision health and mental health markets.

Similar companies to Genomind

Genomind Tech Stack

Genomind uses 8 technology products and services including RSS, Google Cloud, Modernizr, and more. Explore Genomind's tech stack below.

  • RSS
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • Modernizr
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Google
    Search Engines
  • Google Analytics
    Web Analytics
  • MonsterInsights
    Web Platform Extensions
  • Facebook
    Widgets

Media & News

Genomind's Email Address Formats

Genomind uses at least 1 format(s):
Genomind Email FormatsExamplePercentage
First.Last@genomind.comJohn.Doe@genomind.com
26%
FLast@genomind.comJDoe@genomind.com
24%
First.Last@genomind.comJohn.Doe@genomind.com
26%
FLast@genomind.comJDoe@genomind.com
24%

Frequently Asked Questions

What is Genomind's phone number?

Minus sign iconPlus sign icon
You can contact Genomind's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Genomind's official website and social media links?

Minus sign iconPlus sign icon
Genomind's official website is genomind.com and has social profiles on LinkedInCrunchbase.

What is Genomind's SIC code NAICS code?

Minus sign iconPlus sign icon
Genomind's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 62 - Health Care and Social Assistance.

How many employees does Genomind have currently?

Minus sign iconPlus sign icon
As of December 2025, Genomind has approximately 65 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Ceo: B. B.Chief Executive Officer: S. O.Chief Commercial Officer: C. P.. Explore Genomind's employee directory with LeadIQ.

What industry does Genomind belong to?

Minus sign iconPlus sign icon
Genomind operates in the Hospitals and Health Care industry.

What technology does Genomind use?

Minus sign iconPlus sign icon
Genomind's tech stack includes RSSGoogle CloudModernizrUnderscore.jsGoogleGoogle AnalyticsMonsterInsightsFacebook.

What is Genomind's email format?

Minus sign iconPlus sign icon
Genomind's email format typically follows the pattern of First.Last@genomind.com. Find more Genomind email formats with LeadIQ.

How much funding has Genomind raised to date?

Minus sign iconPlus sign icon
As of December 2025, Genomind has raised $11M in funding. .

Genomind

Hospitals and Health CarePennsylvania, United States51-200 Employees

Genomind is a leading precision health company focused on optimizing the treatment experience for individuals and healthcare providers through actionable genetic insights and innovative health technology. Since its founding, Genomind has expanded beyond its flagship of pharmacogenetic testing to develop a comprehensive portfolio of precision health services for individual and population-level patient care. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management, and a new standard of care.

Genomind's Pharmacogenetic Test is an industry-leading prescription genetic test that equips healthcare professionals with tools they need to more quickly identify a personalized treatment plan for their patients. Genomind offers more comprehensive genetic guidance, superior speed and accuracy, state-of-the-art digital tools, and scheduled PhD and PharmD expert consultations. This test is available via clinician order only.

Genomind® Mental Health Map™ is the first-ever genetic test available direct-to-consumer designed specifically for mental health and wellness. It provides powerful new insights and actions through reports in the 7 Core Genetic Mental Health Capabilities™ by analyzing genetic makeup across 35 genes, 38 genetic variants, 21 genetic mechanisms, and 59 mental health predispositions. Included is a free consult to help individuals better take advantage of their results. This test does not inform on medications nor require clinician order.

If you are a patient who is interested in our testing, or a clinician interested in using these tools in your practice, please contact us at 877-895-8658 or customerservice@genomind.com. 
Learn more at www.genomind.com.

Section iconCompany Overview

Phone number
SIC Code
2836 - Biological Products, Except Diagnostic Substances
NAICS Code
62 - Health Care and Social Assistance
Employees
51-200

Section iconFunding & Financials

  • $11M

    Genomind has raised a total of $11M of funding over 1 rounds. .

  • $25M$50M

    Genomind's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $11M

    Genomind has raised a total of $11M of funding over 1 rounds. .

  • $25M$50M

    Genomind's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.